Cargando…
Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix(®)) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs
BACKGROUND: The ability of the topical spot-on Advantix(®) (50 % permethrin/10 % imidacloprid) to prevent transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs has previously been reported. The recent market introduction of chewable tablets containing the novel compounds...
Autores principales: | Jongejan, Frans, Crafford, Dionne, Erasmus, Heidi, Fourie, Josephus J., Schunack, Bettina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912781/ https://www.ncbi.nlm.nih.gov/pubmed/27317101 http://dx.doi.org/10.1186/s13071-016-1636-9 |
Ejemplares similares
-
Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard(®)
por: Liebenberg, Julian, et al.
Publicado: (2017) -
Treatment of canine sarcoptic mange with afoxolaner (NexGard(®)) and afoxolaner plus milbemycin oxime (NexGard Spectra(®)) chewable tablets: efficacy under field conditions in Portugal and Germany
por: Hampel, Verena, et al.
Publicado: (2018) -
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe
por: Lebon, Wilfried, et al.
Publicado: (2018) -
Comparative speed of kill of sarolaner (Simparica™) and afoxolaner (NexGard®) against induced infestations of Rhipicephalus sanguineus s.l. on dogs
por: Six, Robert H., et al.
Publicado: (2016) -
Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae)
por: Alfonso Mendoza-Roldan, Jairo, et al.
Publicado: (2023)